Hi GMT2!
Yes - more good news. Expected - but still good to hear.
I also find it interesting that IMU mentions Gilead's Yescarta. They used similar wording back in October. Gilead has been pushing hard in the CAR-T space and sees it as the future. They paid a shirt load to buy Kite Pharma, who developed Yescarta. $11.9b USD, I believe.
You would have to think that Gilead has been watching OnCARlytics with considerable interest. For that matter - also Azer-Cel.
Cheers
Dave
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-9
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1917207 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 653942 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |